FDA Scientific & Regulatory Support Services(SRS)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA OFFICE OF ACQ GRANT SVCS

Contract Value

Not provided

Codes & Classification
Solicitation Number

75F40127R00007

NAICS

541990 - All Other Professional, Scientific, and Technical Services

Classification Code

R799

Additional Details
Set Aside

SBA

Place of Performance

Silver Spring, Maryland, UNITED STATES

SourceSAM
Documents2
The Food and Drug Administration (FDA), under the Department of Health and Human Services, has issued a Sources Sought Notice (SSN) for Scientific and Regulatory Support Services (SRS), procurement identifier 75F40127R00007. This notice is intended solely for market research and planning purposes and does not constitute a solicitation or a commitment to contract. The FDA is seeking information from qualified vendors, particularly small businesses and those certified under Section 8(a) of the Small Business Act, capable of providing multidisciplinary scientific and regulatory professional services in support of FDA Centers and Offices. Purpose and Scope: The FDA is contemplating the establishment of an Indefinite Delivery Indefinite Quantity (IDIQ) contract to obtain contractor services related to scientific and regulatory support across a broad range of mission requirements. The agency’s primary objective is to secure responsive, high-quality support for scientific research, regulatory review, clinical and nonclinical analyses, epidemiology and surveillance, scientific data interpretation, laboratory activities, technical writing, training, and scientific program coordination. The anticipated period of performance is a five-year ordering period. Key Requirements and Objectives: Vendors must demonstrate the ability to provide scientific depth and operational capacity to: - Conduct scientifically sound analyses and prepare defensible, traceable technical products supporting FDA review and public-health decisions. - Provide qualified personnel across multiple scientific and regulatory disciplines, including specialized and emerging areas. - Support clinical and nonclinical study-data review, standardized scientific datasets, statistical computing, data fitness, quality assessment, and interpretation. - Respond to multiple simultaneous task orders, changing priorities, time-sensitive scientific questions, and evolving requirements across FDA organizations. - Maintain scientific quality, data integrity, documentation, confidentiality, and continuity of performance. - Deliver effective scientific training, technical writing, knowledge transfer, and program-management support tied directly to scientific and regulatory missions. Expected Deliverables: The types of services that may be ordered include, but are not limited to: - Scientific research and regulatory review support, including investigations, literature reviews, study design, methodological assessments, and technical analyses. - Clinical and nonclinical study-data review and analysis, with expertise in standards such as CDISC SDTM, ADaM, and SEND. - Epidemiology, biostatistics, pharmacovigilance, and surveillance, including protocol support, statistical programming, and technical reporting. - Scientific data standards, quality, and analytics, focusing on data preparation, validation, biostatistics, bioinformatics, and computational science. - Laboratory and specialized scientific support, including research assistance, analytical method support, and laboratory findings interpretation. - Scientific writing, training, knowledge management, and communications directly connected to scientific or regulatory activities. - Scientific program and project management, including planning, coordination, milestone tracking, and multidisciplinary collaboration. Contracting Entity and Location: The contracting entity is the FDA Office of Acquisition and Grant Services, a federal office within the Food and Drug Administration. The place of performance is Silver Spring, Maryland, United States. Classification Codes and Set-Aside: - NAICS Code: 541990 (All Other Professional, Scientific, and Technical Services) - Product Service Code: R799 - Set-Aside Type: SBA (Small Business Administration) Special Considerations: The FDA is particularly interested in vendors with demonstrated experience in recruiting and retaining highly specialized scientific and regulatory professionals, including those requiring employment-based visa sponsorship. Vendors should describe their capacity to fill hard-to-recruit positions, maintain continuity of specialized expertise, accommodate surge requirements, and support multiple concurrent task orders. Additionally, vendors should detail their scientific quality-control procedures, data integrity practices, confidentiality controls, and experience handling sensitive regulatory or research information. The agency also seeks information on the application of artificial intelligence (AI), machine learning (ML), or other emerging technologies to scientific research and regulatory review, including responsible use and governance frameworks. Instructions for Respondents: Interested parties are required to submit a concise capability statement (maximum 15 pages, Times New Roman 11 or larger), responses to specific business status questions, and a completed Vendor Feedback Form (Attachment B, not included in the page limit). Responses must include company name, address, point of contact, SAM.gov Unique Entity Identifier (UEI), CAGE code, proposed NAICS code and size status, applicable small-business socioeconomic designations, and anticipated role (prime contractor, joint venture, or subcontractor). Responses should be submitted via email to Amanda Edger, Contract Specialist ([email protected]), with a copy to Ian Weiss, Contracting Officer ([email protected]), by November 23, 2026, at 2:00 pm EST. Constant Elements: Throughout the contract lifecycle, the FDA’s need for multidisciplinary scientific and regulatory support, adherence to high standards of scientific quality and data integrity, and the requirement for responsive, flexible service delivery will remain constant. The scope will consistently focus on scientific and regulatory activities, excluding enterprise IT functions, and will require ongoing collaboration across FDA Centers and Offices. For further information and updates, contractors are encouraged to monitor the official notice at https://sam.gov/opp/a76241f5f0c74a89b4b3cb5584a661b5/view. Primary Contact: Amanda Edger ([email protected]) Secondary Contact: Ian Weiss ([email protected], 301-796-5728) This notice is active and open for responses. Contractors with relevant capabilities and experience are encouraged to participate in this market research to help shape the FDA’s future acquisition strategy for scientific and regulatory support services.